Management of head and neck sarcomas - a tertiary referral institutions 10-year experience

C Thompson, J Yeo, IJ Nixon, IF Nixon

Research output: Contribution to conferencePoster


Background: Head and neck (H&N) sarcoma are rare, constituting only 1 % of all H&N malignancies, and 5% of all sarcoma. Biologically diverse tumour group of many different histological subtypes. Standard treatment involves surgical excision with adjuvant therapy. Anatomical constraints limit achievable surgical margins. Despite advances in surgery and adjuvant therapy, prognosis remains poor. Aims: To report our experience of the management of all patients with histologically confirmed sarcoma of the H&N in NHS Lothian between 2000 and 2010.
Original languageEnglish
Number of pages1
Publication statusPublished - 31 Mar 2017


  • head and neck cancer
  • sarcomas
  • sarcoma treatments

Cite this